Injecting stem cells derived from umbilical cord blood, Wharton's jelly, or exosomes is not permitted by the FDA. — Whalespan
Injecting stem cells derived from umbilical cord blood, Wharton's jelly, or exosomes is not permitted by the FDA.
⚠ High risk
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
✕NOTSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“so what's the reason for that so the FDA has a division that will that regulates the use of human cells tissues and products even if autologous even if you're even if they're your own you can use your own as long as it's not manipulated or what we considered minimally manipulated so spinning is not a manipulation that's right so you can take your bone marrow out of the pelvis and we get it from the pelvis and you can concentrate that but you can't give any enzymes to it you can't digest it you can't make any changes to that product you can only give it as is”